Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • kbora
    Junior Member
    • Feb 2012
    • 4

    #1

    Advice for de novo sequencing strategy

    Hi

    We are considering to do a genome sequencing in one of our filamentous fungi, and would like to have some advices and hear your experiences on some off the different platforms.

    The aim of the sequencing is to find a specific gene cluster involved in biosynthesis of an interesting compound.The fungi has an expected genome size of 30 Mb based on the closest related full genome sequenced fungi.

    Of course the best option is some sort of hybrid strategy, however we don't at the moment have the budget for that. So instead we will just try and sequence on one platform.

    So my questions is:
    1. Which platform will you use for de novo sequencing of a 30 Mb filamentous fungi (at the moment GS-FLX and Illumina HiSeq seems as the best options with the HiSeq being the best and cheapest choice)

    2. We had an offer for sequencing on the HiSeq. However the coverage was above 2000x making the price higher than we expected. How much coverage would you recommend as a minimum in this case?

    3. For the assembly, does any of you have experience in the quality difference between assemblys done with CLC or for instance ABySS?

    Any help would be appreciated.

    Regards,
    Kasper
  • RCJK
    Senior Member
    • May 2009
    • 156

    #2
    You could do a 2x250bp MiSeq run. This could get you around ~250X coverage with longer reads than the HiSeq and a much lower price than the FLX+.

    Comment

    • krobison
      Senior Member
      • Nov 2007
      • 734

      #3
      With any paired-end Illumina strategy, a useful strategy is to size the library so the reads will overlap in the middle; there are a number of tools (such as FLASH) which will then fuse them into a single, higher-quality read.

      100-200X should be quite sufficient. HiSeq will be cheaper than MiSeq, but with shorter readlengths -- and cheaper only if you can ride along with someone else. Running it on 454 is probably going to be quite pricey in comparison.

      It's hard to know which assembler will behave best until you try the data, and you'll need some sort of "ground truth" to sort them out by. I like Ray a lot, as it can distribute very large jobs across multiple nodes in a cluster (I believe ABySS can do this also, but velvet cannot).

      Comment

      • kbora
        Junior Member
        • Feb 2012
        • 4

        #4
        Thx for the advices.

        So far our plan is to sequence 2x100 PE on a HiSeq with a 200x coverage and combine it with a 6 or 10 kb insert library also sequenced on HiSeq.

        Comment

        • jgibbons1
          Senior Member
          • Oct 2009
          • 135

          #5
          I've sequenced a few Aspergillus genomes (30-40 Mb genomes too) looking for secondary metabolite clusters and have found 2x100 PE to be very good with a coverage around 40x. 200x coverage should be great for your assembly.

          SOAPdenovo is my assembler of choice, but ALLPATHS-LG (http://www.broadinstitute.org/softwa...paths-lg/blog/) is supposed to be very good as well. If you plant o use ALLPATHS-LG, I would be sure to take a look at their paper. You have to do some prep work on the library side (2 libraries of different insert sizes) to ensure the algorithm is optimized.

          Comment

          • EricSchon
            Member
            • Nov 2013
            • 10

            #6
            Originally posted by jgibbons1 View Post
            I've sequenced a few Aspergillus genomes (30-40 Mb genomes too) looking for secondary metabolite clusters and have found 2x100 PE to be very good with a coverage around 40x. 200x coverage should be great for your assembly.
            @jgibbons1: Was 40x sufficient to identify the polyketide synthases (PKSs) as well? Since PKSs have very conserved sequences I can imagine that de novo assembly of these regions could generate some problems.

            I will be sequencing Penicillium strains myself also for the purpose of looking secondary metabolism, so I am currently considering how much coverage i need for that. Did you also try to assemble the genome against a reference Aspergillus, or did you only do de novo assebly?

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
              by SEQadmin2



              CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

              Despite this, “CRISPR helped turn genome editing from a specialized technique into
              ...
              Yesterday, 11:01 AM
            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 02:55 AM
            0 responses
            10 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-24-2026, 12:17 PM
            0 responses
            12 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            13 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            24 views
            0 reactions
            Last Post SEQadmin2  
            Working...